Our study has several key findings; (I) NT-proBNP levels are independently linked with in-hospital mortality in COVID-19 pneumonia subjects without HF, (II) NT-proBNP can be utilized as a prognostic biomarker in subjects hospitalized with COVID-19 pneumonia who were free from HF. Here, NPPB is linked to hydrops fetalis.